Related Experiment Video
Updated: Sep 26, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Stem therapy for ALS: hope and reality
1vincenzo@silani.com
Abstract:
All are agreed that there is pressing need for an effective treatment for Amyotrophic Lateral Sclerosis (ALS; MND). Such treatment may derive from a combination of therapeutic strategies aimed at different aspects of the disorder, and might include drugs directed at the initial, intermediate or terminal cascade of events leading to cell death, as well as the use of stem cells to replace dead motor neurons, or to protect those that remain. The attraction of cell implantation or transplantation is that it might help to overcome the inability of the CNS to replace lost neurons. It is also clear that neural implantation will yield little benefit if the donor cells fail to integrate functionally into the recipient CNS circuitry. In this respect, ALS poses an especially difficult problem. The recent breakthroughs in stem cell research might nevertheless provide possibilities for neural implantation and cell replacement therapy for patients with ALS. The potential impact of these new approaches to neurodegenerative diseases has been emphasised by the many experiments using human foetal cell grafts in patients affected by Parkinson's and Huntington's disease. Clinical benefits in Parkinson's disease seem to be associated with integration of the donor cells into the recipient brain. Despite promising results, however, significant constraints have hampered the use of foetal cells for neural implantation and transplantation. Besides ethical concerns, the viability, purity, and final destiny of the foetal tissue have not been completely defined. Foetal cells are, in addition, post-mitotic and cannot be expanded or stored for long periods, necessitating close synchronisation of tissue donation and neurosurgery.
Insights
Effective treatments for Amyotrophic Lateral Sclerosis (ALS) are urgently needed. Stem cell research offers potential for neural implantation and cell replacement therapy, addressing motor neuron loss in ALS.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neuron Disease (MND), lacks effective treatments.
- Current therapeutic strategies aim to target various aspects of the disease cascade, including cell death pathways.
- The central nervous system's (CNS) limited capacity to replace lost neurons presents a significant challenge in treating neurodegenerative diseases like ALS.
Purpose of the Study:
- To explore the potential of stem cell research for neural implantation and cell replacement therapy in ALS.
- To review the challenges and opportunities associated with using cell transplantation to overcome neuronal loss in ALS.
- To examine the applicability of recent stem cell breakthroughs to ALS treatment.
Main Methods:
- Review of current therapeutic strategies for ALS, including pharmacological and cell-based approaches.
- Analysis of the potential of stem cell implantation for replacing or protecting motor neurons.
- Examination of challenges in functional integration of donor cells within the recipient CNS circuitry.
- Consideration of ethical concerns and technical limitations associated with fetal cell transplantation.
Main Results:
- Stem cell research presents promising avenues for neural implantation and cell replacement therapy in ALS.
- Successful integration of donor cells into the recipient CNS is crucial for clinical benefit, as observed in Parkinson's disease.
- Significant constraints, including ethical issues, viability, purity, and expansion limitations of fetal cells, hinder current transplantation approaches.
Conclusions:
- Recent advances in stem cell research may offer new possibilities for ALS treatment through neural implantation.
- Overcoming the challenge of functional integration of transplanted cells is critical for therapeutic success in ALS.
- Addressing ethical and technical limitations is essential for realizing the potential of cell replacement therapy in neurodegenerative diseases.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Gene Therapy
Alzheimer's Disease: Treatment
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
iPS Cell Differentiation
Tumor Immunotherapy

